| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 21:03:46 UTC |
|---|
| Update Date | 2021-09-14 15:45:33 UTC |
|---|
| HMDB ID | HMDB0029120 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Valylalanine |
|---|
| Description | Valylalanine is a dipeptide composed of valine and alanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. |
|---|
| Structure | CC(C)[C@H](N)C(=O)N[C@@H](C)C(O)=O InChI=1S/C8H16N2O3/c1-4(2)6(9)7(11)10-5(3)8(12)13/h4-6H,9H2,1-3H3,(H,10,11)(H,12,13)/t5-,6-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| L-Val-L-ala | ChEBI | | VA | ChEBI | | Valyl-alanine | ChEBI | | L-Valyl-L-alanine | HMDB | | N-L-Valyl-L-alanine | HMDB | | N-Valylalanine | HMDB | | V-a Dipeptide | HMDB | | VA dipeptide | HMDB | | Val-ala | HMDB | | Valine alanine dipeptide | HMDB | | Valine-alanine dipeptide | HMDB | | Valylalanine | ChEBI |
|
|---|
| Chemical Formula | C8H16N2O3 |
|---|
| Average Molecular Weight | 188.227 |
|---|
| Monoisotopic Molecular Weight | 188.116092383 |
|---|
| IUPAC Name | (2S)-2-[(2S)-2-amino-3-methylbutanamido]propanoic acid |
|---|
| Traditional Name | (2S)-2-[(2S)-2-amino-3-methylbutanamido]propanoic acid |
|---|
| CAS Registry Number | 27493-61-4 |
|---|
| SMILES | CC(C)[C@H](N)C(=O)N[C@@H](C)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C8H16N2O3/c1-4(2)6(9)7(11)10-5(3)8(12)13/h4-6H,9H2,1-3H3,(H,10,11)(H,12,13)/t5-,6-/m0/s1 |
|---|
| InChI Key | HSRXSKHRSXRCFC-WDSKDSINSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Valine or derivatives
- N-acyl-l-alpha-amino acid
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alanine or derivatives
- Alpha-amino acid or derivatives
- Fatty acyl
- Fatty amide
- N-acyl-amine
- Amino acid or derivatives
- Carboxamide group
- Amino acid
- Carboxylic acid salt
- Secondary carboxylic acid amide
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Primary amine
- Organic zwitterion
- Organic nitrogen compound
- Primary aliphatic amine
- Organic salt
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -2.49 | Extrapolated |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.49 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.0782 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.48 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 288.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 856.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 269.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 65.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 158.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 44.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 283.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 259.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 508.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 625.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 158.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 767.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 162.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 181.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 419.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 433.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 233.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Valylalanine,1TMS,isomer #1 | CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1612.4 | Semi standard non polar | 33892256 | | Valylalanine,1TMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O | 1634.6 | Semi standard non polar | 33892256 | | Valylalanine,1TMS,isomer #3 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1637.1 | Semi standard non polar | 33892256 | | Valylalanine,2TMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1702.2 | Semi standard non polar | 33892256 | | Valylalanine,2TMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1667.9 | Standard non polar | 33892256 | | Valylalanine,2TMS,isomer #2 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1621.7 | Semi standard non polar | 33892256 | | Valylalanine,2TMS,isomer #2 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1702.8 | Standard non polar | 33892256 | | Valylalanine,2TMS,isomer #3 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1802.3 | Semi standard non polar | 33892256 | | Valylalanine,2TMS,isomer #3 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1692.7 | Standard non polar | 33892256 | | Valylalanine,2TMS,isomer #4 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1705.5 | Semi standard non polar | 33892256 | | Valylalanine,2TMS,isomer #4 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1680.3 | Standard non polar | 33892256 | | Valylalanine,3TMS,isomer #1 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1824.4 | Semi standard non polar | 33892256 | | Valylalanine,3TMS,isomer #1 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1784.6 | Standard non polar | 33892256 | | Valylalanine,3TMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1710.4 | Semi standard non polar | 33892256 | | Valylalanine,3TMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1752.9 | Standard non polar | 33892256 | | Valylalanine,3TMS,isomer #3 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1834.8 | Semi standard non polar | 33892256 | | Valylalanine,3TMS,isomer #3 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1827.3 | Standard non polar | 33892256 | | Valylalanine,4TMS,isomer #1 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1916.8 | Semi standard non polar | 33892256 | | Valylalanine,4TMS,isomer #1 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1903.0 | Standard non polar | 33892256 | | Valylalanine,1TBDMS,isomer #1 | CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 1857.5 | Semi standard non polar | 33892256 | | Valylalanine,1TBDMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O | 1875.9 | Semi standard non polar | 33892256 | | Valylalanine,1TBDMS,isomer #3 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 1863.8 | Semi standard non polar | 33892256 | | Valylalanine,2TBDMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 2128.8 | Semi standard non polar | 33892256 | | Valylalanine,2TBDMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 2080.8 | Standard non polar | 33892256 | | Valylalanine,2TBDMS,isomer #2 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2072.1 | Semi standard non polar | 33892256 | | Valylalanine,2TBDMS,isomer #2 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2143.3 | Standard non polar | 33892256 | | Valylalanine,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2260.8 | Semi standard non polar | 33892256 | | Valylalanine,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2092.8 | Standard non polar | 33892256 | | Valylalanine,2TBDMS,isomer #4 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2150.0 | Semi standard non polar | 33892256 | | Valylalanine,2TBDMS,isomer #4 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2083.6 | Standard non polar | 33892256 | | Valylalanine,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2491.1 | Semi standard non polar | 33892256 | | Valylalanine,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2361.6 | Standard non polar | 33892256 | | Valylalanine,3TBDMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2366.2 | Semi standard non polar | 33892256 | | Valylalanine,3TBDMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2337.5 | Standard non polar | 33892256 | | Valylalanine,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2504.3 | Semi standard non polar | 33892256 | | Valylalanine,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2403.0 | Standard non polar | 33892256 | | Valylalanine,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2748.6 | Semi standard non polar | 33892256 | | Valylalanine,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2632.7 | Standard non polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Valylalanine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 10V, Negative-QTOF | splash10-000i-8900000000-809bdd0688622d28889d | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 20V, Negative-QTOF | splash10-000i-9100000000-bdd25007d91e14c08370 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 40V, Negative-QTOF | splash10-0006-9000000000-f51e4d54854c853b7498 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 10V, Positive-QTOF | splash10-00dr-9500000000-3240d8b1d432f74cd148 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 20V, Positive-QTOF | splash10-00di-9000000000-a278ac1b63487fce4806 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 40V, Positive-QTOF | splash10-05fu-9000000000-26d47cd3c8e74226ee49 | 2021-09-23 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | Not Available |
|---|
| Biospecimen Locations | |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|
| Associated OMIM IDs | |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB112122 |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | 5360762 |
|---|
| KEGG Compound ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | 6992637 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 75008 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| MarkerDB ID | Not Available |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| Material Safety Data Sheet (MSDS) | Not Available |
|---|
| General References | - Wallace RJ, McKain N, Broderick GA, Rode LM, Walker ND, Newbold CJ, Kopecny J: Peptidases of the rumen bacterium, Prevotella ruminicola. Anaerobe. 1997 Feb;3(1):35-42. [PubMed:16887560 ]
- Macfarlane S, Macfarlane GT: Formation of a dipeptidyl arylamidase by Bacteroides splanchnicus NCTC 10825 with specificities towards glycylprolyl-x and valylalanine-x substrates. J Med Microbiol. 1997 Jul;46(7):547-55. [PubMed:9236738 ]
- Kawashiro K, Ishizaki H, Sugiyama S, Hayashi H: Esterification of N-benzyloxycarbonyldipeptides in ethanol-water with immobilized papain. Biotechnol Bioeng. 1993 Jul;42(3):309-14. [PubMed:18613014 ]
|
|---|